Innealta Capital LLC Purchases Shares of 380 Addus HomeCare Co. (NASDAQ:ADUS)

Innealta Capital LLC bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 380 shares of the company’s stock, valued at approximately $44,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Principal Securities Inc. acquired a new stake in shares of Addus HomeCare during the 4th quarter worth about $26,000. GAMMA Investing LLC acquired a new stake in shares of Addus HomeCare during the 4th quarter worth about $34,000. EntryPoint Capital LLC acquired a new stake in shares of Addus HomeCare during the 1st quarter worth about $44,000. Assetmark Inc. raised its position in shares of Addus HomeCare by 33.3% during the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. acquired a new stake in shares of Addus HomeCare during the 1st quarter worth about $234,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on ADUS shares. Oppenheimer raised their target price on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. TD Cowen lifted their price target on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Macquarie started coverage on Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target on the stock. Finally, Stephens reaffirmed an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $127.57.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,186,500.21. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Performance

Shares of ADUS stock traded up $1.93 during midday trading on Friday, hitting $133.01. The company had a trading volume of 123,415 shares, compared to its average volume of 135,177. The company’s 50 day simple moving average is $123.16 and its 200 day simple moving average is $109.83. Addus HomeCare Co. has a 52-week low of $78.35 and a 52-week high of $134.78. The stock has a market cap of $2.41 billion, a price-to-earnings ratio of 32.53, a PEG ratio of 2.35 and a beta of 1.01. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The company had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. During the same period last year, the business posted $0.94 EPS. The company’s revenue was up 10.4% on a year-over-year basis. Research analysts anticipate that Addus HomeCare Co. will post 4.36 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.